Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease
Overview
Affiliations
Background And Aims: Individuals with inflammatory bowel disease experience debilitating symptoms on a daily basis, but little is known about symptom burden in IBD. The objectives were to (i) identify the most prevalent symptoms and the average number of symptoms experienced; (ii) assess symptom frequency, severity and distress; and (iii) determine the most burdensome symptoms experienced by individuals with inflammatory bowel disease.
Methods: A cross-sectional descriptive design was used to collect data in a single regional treatment centre in Ireland. A consecutive and unique sample of 247 individuals diagnosed with Crohn's disease and ulcerative colitis completed a modified disease-specific version of the Memorial Symptom Assessment Scale.
Results: Participants reported experiencing a median of 10 symptoms during the last week, but as many as 16 symptoms were experienced by those with active disease. Of the symptoms experienced, lack of energy was identified as the most burdensome symptom. Bowel symptoms of urgency and diarrhoea and irritable bowel syndrome-type symptoms such as feeling bloated and flatulence were also problematic. Worry was ranked the most burdensome psychological symptom experienced. Symptom burden scores varied according to disease type and disease status, with significant differences found between those with active and inactive disease.
Conclusions: Individuals with inflammatory bowel disease experience a considerable number of symptoms and are burdened by both physical and psychological symptoms, particularly during active disease. Healthcare professionals' focus of assessment needs to be broadened to encompass multiple symptoms. Greater attention needs to be given to fatigue and psychological symptoms.
Lewis J, Vadhariya A, Su S, Zhou X, Durand F, Kawata A J Patient Rep Outcomes. 2025; 9(1):19.
PMID: 39962027 PMC: 11833035. DOI: 10.1186/s41687-025-00851-y.
Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases.
Atanasova K, Knodler L, Reindl W, Ebert M, Thomann A Semin Immunopathol. 2025; 47(1):12.
PMID: 39870972 PMC: 11772462. DOI: 10.1007/s00281-025-01036-x.
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.
Centanni L, Cicerone C, Fanizzi F, DAmico F, Furfaro F, Zilli A Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861141 PMC: 11768140. DOI: 10.3390/ph18010078.
Deconditioning in quiescent Crohn's disease patients with heightened fatigue perception.
McGing J, Serres S, Nicholas R, Gupta A, Radford S, Nixon A J Crohns Colitis. 2025; 19(1).
PMID: 39787044 PMC: 11786219. DOI: 10.1093/ecco-jcc/jjae194.
Fatigue in children and adolescents with inflammatory bowel disease: a cross-sectional study.
Zuo Y, Cao J, Wang Y, Cai W, Li M Front Pediatr. 2025; 12:1519779.
PMID: 39748815 PMC: 11693721. DOI: 10.3389/fped.2024.1519779.